Integra LifeSciences Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Integra LifeSciences (IART) Tops Q2 EPS by 23c
August 10, 2020 4:22 PM EDTIntegra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.33, $0.23 better than the analyst estimate of $0.10. Revenue for the quarter came in at $258.7 million versus the consensus estimate of $242.8 million.
The Company's full-year 2020 guidance remains withdrawn due to the uncertainty related to COVID-19 and... More
